NEW YORK, April 09, 2018 -- Guggenheim Partners is now accepting applications for the Network for Social Innovation (NSI), the firm’s venture philanthropy program designed to identify and support the growth of visionary non-profit organizations tackling some of the most challenging issues of our time.
Through the Network for Social Innovation, Guggenheim Partners will invest $100,000 in several high-performing, early-stage, non-profit organizations leveraging innovative solutions to solve enduring social problems. In addition, the firm will deploy its “creative capital” -- any non-financial contribution that Guggenheim Partners can provide through accessing its employees’ and networks’ specialized skills and resources. In 2016, Guggenheim welcomed six non-profit organizations into the Network for Social Innovation and looks forward to expanding the cohort before the end of 2018.
“We are thrilled to combine our financial and creative capital to drive social impact through the Network for Social Innovation,” said Lauren Coape-Arnold, Head of Corporate Social Responsibility at Guggenheim Partners. “The launch of our second NSI request for proposal marks another important milestone in the development and growth of Guggenheim’s commitment to social change.”
Interested and eligible non-profit organizations may submit applications online at www.guggenheimpartners.com/NSI. Applications are due by May 31 at 5:00 p.m. ET. Vetting will occur in multiple rounds, and organizations will be selected by year-end.
About Guggenheim Partners
Guggenheim Partners is a global investment and advisory firm with more than $305 billion1 in assets under management. Across our three primary businesses of investment management, investment banking, and insurance services, we have a track record of delivering results through innovative solutions. With over 2,300 professionals based in more than 25 offices around the world, our commitment is to advance the strategic interests of our clients and to deliver long-term results with excellence and integrity. We invite you to learn more about our expertise and values by visiting GuggenheimPartners.com and following us on Twitter at twitter.com/guggenheimptnrs.
1 Assets under management are as of 12.31.2017 and include consulting services for clients whose assets are valued at approximately $66bn.
The preparation and distribution of this press release does not constitute a form of commitment or recommendation relating to the proposed grant of capital. The information contained herein is as of the date indicated and reflects present intention only. This information is subject to change at any time, and Guggenheim Partners is under no obligation to provide recipient with any updates or amendments to this press release.
Media Contact
Ellen Cunningham
Guggenheim Partners
212.518.9578 office
[email protected]


Treasury Wine Estates Shares Surge After U.S. Dispute Settlement and Earnings Upgrade
Moderna Stock Drops After FDA Declines Review of mRNA Flu Vaccine
SMIC Shares Slide Despite Strong AI-Driven Earnings as Margin Pressure Looms
Samsung Electronics Sees Sustained AI-Driven Demand for Memory Chips Into Next Year
Ralph Lauren Unveils Elegant Fall 2026 Women’s Collection Ahead of New York Fashion Week
Macquarie Group Shares Jump as Third-Quarter Trading Conditions Improve Across Key Units
xAI Co-Founder Jimmy Ba Departs as Elon Musk’s AI Startup Faces Turbulence
American Airlines CEO to Meet Pilots Union Amid Storm Response and Financial Concerns
Alphabet Plans Rare 100-Year Sterling Bond to Fund AI Expansion
FDA Rejects Review of Moderna’s Flu Vaccine Application, Shares Slide
Air New Zealand Cabin Crew Strike Set for February 12–13 Amid Failed Talks
DBS Expects Slight Dip in 2026 Net Profit After Q4 Earnings Miss on Lower Interest Margins
Taiwan Says Moving 40% of Semiconductor Production to the U.S. Is Impossible
FAA Confirms $1.5 Billion Peraton Contract as U.S. Air Traffic Control Overhaul Accelerates
Petrobras Posts Record Oil Exports as Production Surge Fuels Global Expansion
Cloudflare Forecasts Strong Revenue Growth as AI Fuels Cloud Services Demand
Innovent Biologics Shares Rally on New Eli Lilly Oncology and Immunology Deal 



